MATTHEW CARL ALLGEIER,DANIEL L. FLYNN,MICHAEL D. KAUFMAN,PHENIL J. PATEL,CRAIG D. WOLFANGEL
申请号:
PH12014501986
公开号:
PH12014501986B1
申请日:
2014.09.05
申请国别(地区):
PH
年份:
2014
代理人:
摘要:
The present invention provides a pyrido[2,3-d]pyrimidine compound, or a pharmaceutically acceptable salt thereof, that inhibits Raf and, therefore, may be useful in treating cancer.